A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.
Public ClinicalTrials.gov record NCT00249782. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Partial-Blind, Parallel-Group, Active- and Vehicle-Controlled, Multicenter Study of the Safety and Efficacy of ACZONE™ (Dapsone) Gel, 5% in Subjects With Papulopustular Rosacea
Study identification
- NCT ID
- NCT00249782
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Allergan
- Industry
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Interventions
- Vehicle control, 2x/day Drug
- ACZONE (dapsone) Gel, 5%, 2x/day Drug
- ACZONE (dapsone) Gel, 5%, 1x/day Drug
- MetroGel® (metronidazole gel), 1.0% 1x/day Drug
- ACZONE (dapsone) Gel, 5%, 1x/day (AM) + MetroGel (metronidazole gel), 1.0%, 1x/day (PM) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2005
- Primary completion
- Apr 30, 2006
- Completion
- Apr 30, 2006
- Last update posted
- May 29, 2011
2005 – 2006
United States locations
- U.S. sites
- 26
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Radiant Research | Birmingham | Alabama | 35209 | — |
| Radiant Research | Tucson | Arizona | 85710 | — |
| East Bay Dermatology Medical Group, Inc. | Fremont | California | 94538 | — |
| Therapeutics Clinical Research | San Diego | California | 92123 | — |
| Clincial Research Specialists, Inc. | Santa Monica | California | 90404 | — |
| Cherry Creek Research, Inc | Denver | Colorado | 80246 | — |
| The Savin Center, PC | New Haven | Connecticut | 06511 | — |
| Visions Clinical Research | Boynton Beach | Florida | 33437 | — |
| Tampa Bay Medical Research | Clearwater | Florida | 33761 | — |
| FXM Research | Miami | Florida | 33175 | — |
| University Clinical Research, Inc. | Pembroke Pines | Florida | 33024 | — |
| MedaPhase, Inc. | Newnan | Georgia | 30263 | — |
| Welborn Clinic | Evansville | Indiana | 478713 | — |
| Dermatology Clinical Trials Unit Washington University | St Louis | Missouri | 63110 | — |
| Skin Specialists, PC | Omaha | Nebraska | 68144 | — |
| Academic Dermatology Associates | Albuquerque | New Mexico | 87106 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| University Dermatology Consultants, Inc. | Cincinnati | Ohio | 45219 | — |
| Dermatology Research Associates Inc. | Cincinnati | Ohio | 45230 | — |
| Northwest Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Oregon Medical Research Center | Portland | Oregon | 97223 | — |
| Paddington Testing Co., Inc. | Philadelphia | Pennsylvania | 19103 | — |
| Dermatology Research Association, Inc. | Nashville | Tennessee | 37203 | — |
| DermResearch, Inc. | Austin | Texas | 78759 | — |
| J&S Studies Inc. | Bryan | Texas | 77802 | — |
| Madison Skin & Research, Inc. | Madison | Wisconsin | 53719 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00249782, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 29, 2011 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00249782 live on ClinicalTrials.gov.